doi:10.1017/s0007114516003858 Rezaie P, Bitarafan V, Horowitz M, Feinle-Bisset C
PMC 3018069
Through robust clinical studies and real-world evidence from 2023-2025, these combination therapies have proven to significantly improve glycemic control, facilitate weight loss, and reduce the burden of daily insulin doses
So I think rather than focusing on the BMI per se, you want to focus on a healthy weight for the person, right
You can overcome cravings and lose weight with GLP-1 weight loss treatments in our area
Developed through advanced peptide engineering, it simultaneously activates the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), allowing researchers to investigate coordinated signaling across two complementary endocrine pathways